Asset Management One’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,634
Closed -$398K 918
2025
Q4
$398K Sell
6,634
-81,858
-93% -$4.46M ﹤0.01% 830
2025
Q3
$4.79M Buy
88,492
+529
+0.6% +$30.3K 0.01% 620
2025
Q2
$4.84M Buy
87,963
+7,084
+9% +$417K 0.02% 611
2025
Q1
$5.72M Buy
80,879
+4,094
+5% +$275K 0.02% 577
2024
Q4
$5.14M Buy
76,785
+283
+0.4% +$19K 0.02% 608
2024
Q3
$5.38M Sell
76,502
-1,264
-2% -$106K 0.02% 603
2024
Q2
$6.4M Sell
77,766
-2,788
-3% -$232K 0.02% 515
2024
Q1
$7.04M Sell
80,554
-539
-0.7% -$48.3K 0.03% 507
2023
Q4
$7.88M Sell
81,093
-4,789
-6% -$424K 0.03% 465
2023
Q3
$7.6M Sell
85,882
-1,118
-1% -$99.5K 0.03% 450
2023
Q2
$7.54M Buy
87,000
+1,997
+2% +$188K 0.03% 474
2023
Q1
$8.27M Sell
85,003
-4,158
-5% -$431K 0.04% 450
2022
Q4
$9.14M Sell
89,161
-5,995
-6% -$563K 0.04% 412
2022
Q3
$8.07M Buy
95,156
+8,182
+9% +$729K 0.04% 430
2022
Q2
$7.21M Sell
86,974
-2,004
-2% -$160K 0.03% 480
2022
Q1
$6.86M Sell
88,978
-3,707
-4% -$310K 0.03% 556
2021
Q4
$8.3M Buy
92,685
+12,210
+15% +$1.01M 0.03% 531
2021
Q3
$6.22M Buy
80,475
+1,416
+2% +$112K 0.02% 595
2021
Q2
$6.6M Sell
79,059
-5,423
-6% -$430K 0.02% 596
2021
Q1
$6.38M Sell
84,482
-2,231
-3% -$182K 0.03% 592
2020
Q4
$7.48M Sell
86,713
-7,985
-8% -$633K 0.03% 531
2020
Q3
$7.2M Buy
94,698
+3,957
+4% +$400K 0.03% 484
2020
Q2
$11.2M Sell
90,741
-2,518
-3% -$250K 0.06% 349
2020
Q1
$7.88M Buy
93,259
+2,457
+3% +$212K 0.05% 380
2019
Q4
$7.68M Sell
90,802
-4,310
-5% -$326K 0.03% 490
2019
Q3
$6.41M Buy
95,112
+1,091
+1% +$84K 0.03% 518
2019
Q2
$8.05M Buy
94,021
+65
+0.1% +$5.56K 0.04% 466
2019
Q1
$8.35M Sell
93,956
-201,430
-68% -$18.7M 0.05% 428
2018
Q4
$25.1M Buy
295,386
+10,259
+4% +$976K 0.06% 340
2018
Q3
$27.7M Buy
285,127
+3,076
+1% +$307K 0.06% 366
2018
Q2
$26.5M Buy
282,051
+11,808
+4% +$1.03M 0.06% 363
2018
Q1
$21.9M Buy
270,243
+9,216
+4% +$791K 0.05% 410
2017
Q4
$23.3M Sell
261,027
-9,531
-4% -$829K 0.05% 392
2017
Q3
$25.2M Sell
270,558
-560
-0.2% -$49.5K 0.06% 351
2017
Q2
$24.6M Sell
271,118
-5,507
-2% -$501K 0.06% 339
2017
Q1
$24.3M Sell
276,625
-9,310
-3% -$828K 0.06% 331
2016
Q4
$23.7M Buy
285,935
+257,391
+902% +$22.1M 0.06% 335
2016
Q3
$2.65M Buy
28,544
+9,366
+49% +$882K 0.04% 516
2016
Q2
$1.5M Buy
19,178
+4,392
+30% +$373K 0.02% 719
2016
Q1
$1.16M Sell
14,786
-1,086
-7% -$88.4K 0.02% 821
2015
Q4
$1.68M Sell
15,872
-2,376
-13% -$248K 0.03% 672
2015
Q3
$1.79M Buy
18,248
+250
+1% +$33.4K 0.03% 662
2015
Q2
$2.4M Sell
17,998
-2,206
-11% -$273K 0.03% 598
2015
Q1
$2.59M Buy
20,204
+6,479
+47% +$686K 0.03% 610
2014
Q4
$1.26M Sell
13,725
-2,329
-15% -$194K 0.02% 784
2014
Q3
$1.17M Hold
16,054
0.02% 764
2014
Q2
$1.01M Hold
16,054
0.02% 762
2014
Q1
$1.07M Buy
16,054
+462
+3% +$34K 0.02% 701
2013
Q4
$1.08M Sell
15,592
-91
-0.6% -$6.18K 0.02% 706
2013
Q3
$1.16M Sell
15,683
-16,321
-51% -$1.08M 0.02% 691
2013
Q2
$1.81M Buy
+32,004
New +$1.99M 0.03% 513

Other funds holding BMRN